Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sarilumab for Patients With Moderate COVID-19 Disease: A Randomized Controlled Trial With a Play-The-Winner Design

NCT04359901 is registered in ClinicalTrials.gov with Westyn Branch-Elliman as lead sponsor.

NCT NCT04359901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04359901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sarilumab for Patients With Moderate COVID-19 Disease: A Randomized Controlled Trial With a Play-The-Winner Design
Lead sponsor
Westyn Branch-Elliman
Phase
Phase 2
Overall status
Completed
Start date
April 10, 2020
Completion date
August 2, 2021
Enrollment
50 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid